Skip to main content
Contact +1 (919) 234-1277

Get 25% off your first bioreagent online order — use code: PROTEOSHOP25
Brand: ProteoGenix

Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade

Isotype:
IgG4, Kappa

$143.00

100ug + 143 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb
Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb binds to CD137 Recombinant Protein in Indirect ELISA Assay

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade

Product name Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade
Source CAS 934823-49-1
Species Homo sapiens
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Urelumab,BMS-663513,TNFRSF9, CD137 ,anti-TNFRSF9, CD137
Reference PX-TA1265
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody
Product name Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb - Research Grade
Source CAS 934823-49-1
Species Homo sapiens
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Urelumab,BMS-663513,TNFRSF9, CD137 ,anti-TNFRSF9, CD137
Reference PX-TA1265
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4-kappa
Clonality Monoclonal Antibody

General information on Anti-TNFRSF9/CD137 [Homo sapiens] (Urelumab) Monoclonal Antibody

Urelumab is a human antibody targeting CD137. Urelumab has been investigated for the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, Cancer – Solid Tumors and B-Cell Non-Hodgkin’s Lymphoma.

SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb

SDS-PAGE for Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb, on SDS-PAGE under reducing and non-reducing conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb binds to CD137 Recombinant Protein in Indirect ELISA Assay

Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb binds to CD137 Recombinant Protein in Indirect ELISA Assay

Immobilized CD137 Recombinant Protein (cat. No.PX-P4107) at 0.5µg/mL (100µL/well) can bind to Urelumab Biosimilar - Anti-TNFRSF9, CD137 mAb (cat. No.PX-TA1265) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Urelumab Biosimilar – Anti-TNFRSF9, CD137 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products